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The Gram-positive Enterococci are present as gastrointestinal tract normal microflora in both healthy 
humans and animals. These have the ability to colonize wounds and ulcers in hospitalized people. 
Enterococci are attributed as second major cause of bloodstream infections (BSI) the third for hospital 
acquired infections (HAI)1. About 14% of HAI have reportedly been caused by Enterococci2. More than 40 
species have been identified as part of Enterococcus genus, however E. faecium and E. faecalis have 
emerged as major cause of human infections comprise 75% and 20% of human infections, respectively3-4. A 
recent Chinese study reported E. faecium as compared to E. faecalis that accounted for more bloodstream 
infections with 24% mortality rate in total5. Emergence of moderate to high level drug resistance has been 
attributed for the failure of eradication therapy in enterococcal infections2.  
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Abstract 
Vancomycin resistant Enterococci have emerged rapidly in the recent years 
leading to treatment failure. The aim of this work was to identify 
vancomycin resistance determinants; vanA and vanB genes in Enterococci.  
The blood, urine and throat samples were collected from 150 patients from 
local hospitals of twin cities of Rawalpindi/Islamabad. Forty-nine 
phenotypically confirmed isolates were further confirmed by PCR 
amplification for vancomycin determinants (genes for vanA and vanB) for 
vancomycin resistant Enterococci. Dependence and frequency distribution 
of VRE and VSE bacteraemia with respect to age, gender and source was 
also studied. Phenotypically resistant strains were positive for vanA while 
negative for vanB. vancomycin susceptible enterococci (VSE) could be 
isolated more from urine samples as compared to blood whereas 
vancomycin resistant enterococci (VRE) was found more prevalent in the 
blood samples (p value= 0.000). VRE was more frequently isolated from 
patients aged 50 or above whereas VSE prevalence was same in both age 
groups (p value=0.002). Gender was not found to have any significant 
impact on VRE or VSE bacteraemia. This study reports vanA gene cluster 
responsible for resistance in Pakistani population and frequently isolation 
of VRE from blood samples. 
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The emergence of multi drug resistant (MDR) enterococcal species is attributed to both horizontal and 
vertical transfer of resistant determinants. Enterococci became resistant to glycopeptides (vancomycin and 
teicoplanin) by acquiring genes through plasmid or transposon that enabled bacteria to bypass antibiotic 
susceptible critical steps in cell wall formation6. The intrinsic resistance of enteroccci against β-lactam 
antibiotics and such transposon mediated horizontal transfer of vancomycin resistance genes have limited 
the use of these antimicrobials for treating VRE.  
Since its first use in 1958, vancomycin has been used for the treatment of Gram positive bacterial infections 
as it effectively blocks the cell wall formation by targeting its building blocks7. The resistance determinant 
against vancomycin is a gene complex that expresses to synthesize the abnormal precursor of 
peptidoglycan to which vancomycin binds with very low affinity. vanA and vanB being the dominant genes 
in clinically important enterococcal species (E. fecalis and E. faecium) are present on mobile elements that 
jump across species to confer resistance. Employing these jumping genes, VRE can horizontally transfer its 
resistant determinants to VSE and other organisms like Gram positive S. aureus8-9. 
High level resistance with MIC of more than 64 μg/ ml against vancomycin and moderate resistance with 
MIC of over 16 μg/ ml against toteicoplanin is conferred by vanA10. The resistance level (MICs, 4->256 
mg/ml) in vanB is lower than vanA and is attributed to VanB ligase enzyme that converts D-Ala-D-Ala to D-
Ala-D-Lac, perhaps due to less substitution11. According to geographic distribution reports about vanA and 
vanB genotypes, vanA is frequently found in Europe, most US states and in most countries of Asia12. The 
gene cluster reported for both vanA and vanB is of 1.3 kb (www.ncbi.nlm.nih.gov). 
The major objective of our study was to ascertain the resistance determinants frequently found in Pakistan 
that confer resistance to E. faecalis and E. faecium and also analyze significance of the clinical data of 
patients for occurrence of VRE or VSE bacteraemia. 
2.   MATERIALS AND METHODS 
2.1 Patient’s clinical data 
Data including age of the patients (divided into two groups of upto 50 years and above 50 years), gender, 
history of vancomycin treatment, surgical procedures and current medication profile was collected from 
the hospital record. 
2.2 Clinical Isolates of Enterococcus 
The blood, urine and throat samples were collected from 150 patients of local hospitals providing tertiary 
care to the patients of twin cities of Rawalpindi/Islamabad during seven months of the study period. 
Written consents were taken from the patients and guardians before sampling and study was approved 
from concerned bodies. Forty nine clinical isolates of Enterococcus were identified using biochemical tests.  
Among these were 13 vancomycin resistant E. faecium, 11 vancomycin sensitive E. faecium, 5 vancomycin 
resistant E. faecalis, and 20 vancomycin sensitive E. faecalis. Disc diffusion was used to test antibiotic 
susceptibility testing and MIC recorded. Plates of Azide Dextrose agar were used to maintain vancomycin 
susceptible strains and those of nutrient agar with 60 µg/ml vancomycin were used for vancomycin 
resistant strains. 
2.3 Antimicrobial Susceptibility Testing 
Plasmid Extraction 
Luria Bertani (LB) broth was used to grow desired bacterial strain and growth was harvested during 
logarithmic phase (O.D600 of 0.6). Plasmid Extraction Kit (Invitrogen, Life Technologies) was used to isolate  
high copy number of plasmid. The plasmid obtained was checked using 1% agarose gel. 
Primer Designing 
Primers were designed for both vanA and vanB genes. The gene sequences were obtained from NCBI. 
Oligocalc program was used to analyze the GC content, Tm and complementarity properties of both 
primers. BLAST and ClustalW programs were used for specificity and proper alignment, respectively. Primer 
set for vanA included: Forward primer: 5́-GAGGAGCATGACGTATCGGTA-3 ́ and reverse primer: 5́- 
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CGATCAAGCGGTCAAT CAGT-3.́ The primer set for vanB included; Forward primer: 5́-
GTTGCTCGGAGGAACATGAT-3,́ and reverse primer: 5́-GATAGCGGCTGTACGATGTA-3.́ 
2.4 Molecular Identification 
PCR amplification was carried out for vanA and vanB genes using the respective primers. PCR profile 
included denaturation initially at 94oC for 4 minutes that was followed by 35 cycles of denaturation, 
annealing and elongation (94oC for 45 seconds, 55oC for 1 minute and 72oC for 2 minutes). Final elongation 
for 7 minutes was done at 72oC. The resultant PCR product was analyzed on 1% agarose gel and 1 kb ladder 
for size estimation. 
2.5 Statistical Analysis  
SPSS 16.0 was used for data analysis and graphs were made with GraphPad Prism 5.0 software. The 
significance of data was analyzed using Chi-square test. 
3. RESULTS AND DISCUSSIONS  
3.1 Presence of vanA in VRE 
The primers for vanA and vanB gene cluster gave the desired PCR amplicon of approximately 936 bp for all 
VRE isolate (5 vancomycin resistant E. faecalis 13 and vancomycin resistant E. faecium (Fig. 1) that 
confirmed the resistant nature of the isolates. 
 
Fig. 1: PCR amplification of vanA gene of approximately 936 bp. Lane 1 shows 1 kb ladder while lane 2 – 
19 shows vancomycin resistant E. faecium and E. faecalis 
3.2 Relationship of VRE and VSE bacteraemia with age, gender and source 
Age and source had significant impact on VRE and VSE bacteraemia occurrence while gender had no such 
impact (Table 1, Fig. 2). VRE was found significantly more prevalent in age group of over 50 years (p = 
0.002) whereas VSE was observed in both age groups albeit with higher occurrence in below 50 group. 
Similarly VSE was mostly isolated from urine samples with few from blood as compared to VRE that was 
more frequent in blood (p =0.000). Gender analysis showed revealed both VSE and VRE were more in males 
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Table 1: Frequency distribution of VRE and VSE bacteraemia related to age, gender and source and 
significance of each variable on VRE and VSE occurrence. 






























































Fig. 2: VRE and VSE bacteraemia occurrence on the basis of different (A) age groups (B) sample sources 
and (C) gender. 
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4. DISCUSSION 
E. faecalis and E. faecium are notorious for hospital acquired infections across the world, E faecium being 
the most important because of its high resistance to antimicrobials and high mortality rate1,13. Resistance 
against a number of commonly used antibiotics like beta-lactams, glycopeptides and aminoglycosides is the 
most important feature of both E. faecalis and E. faecium8. Medical community acknowledges the ever 
increasing resistance against vancomycin and its spread to other species, and consequent emergence of 
multi-drug resistant microbes as a huge problem14. The determinants responsible for vancomycin 
resistance in Enterococci are predominantly vanA and vanB; vanA being common among most geographic 
locations15.  
Treatment options for VRE include drugs like tigecycline, linezolid, daptomycin, quinipristin-dalfopristin, 
platensimycin, nitrofurantoin and fosfomycin. However, some reports of resistance are also documented 
against these as well16. These organisms have become a challenge for physicians due to their high mortality 
and morbidity rate17. 
In this study 49 clinical isolates of E. faecium and E. faecalis obtained from various hospitals of Islamabad 
and Rawalpindi revealed that vancomycin resistance might be rapidly spreading in this part of Pakistan. 
Among 49 strains, 18 were phenotypically resistant to vancomycin (data not sown) while others were 
susceptible for it. All strains were subjected to PCR amplification for vanA and vanB gene cluster. 
Phenotypically resistant strains were positive for vanA while no strain was positive for vanB. Bands of 
approximately 936 bp were obtained for vanA gene which is in accordance with a previous report18. The 
localization of vanA gene on plasmid DNA was also in accordance with published data19.  
The possible explanation of vanB absence may be attributed to difference in the prevalence of these genes 
in the study area, a finding in line with previously published reports from India15. Although vanB gene has 
been reported in Spanish, English and American isolates, it was far less than vanA20-21. Studies from Korea 
and Taiwan have, however reported vanB presence on a higher level22-23. Our findings were in conformance 
with vanA prevalence in neighbouring India so it can be suggested that geographic distribution leads to the 
prevalence of vanA gene in Pakistani population. 
The statistical analysis revealed two dependant factors being age and source for bacteraemia due to both 
VRE and VSE. Gender emerged as an independent factor for both cases, albeit with increased proportion 
for male patients. A possible explanation for higher age dependence in VRE bacteraemia may lie in the fact 
that Entercoccal Surface Protein (ESP) causes immune evasion in elderly patients who already have a 
compromised immunity. Increased exposure to the antibiotics in elderly patients might have contributed to 
this phenomenon.  
Frequent isolation of VRE from blood samples may be attributed to the opportunistic nature of organism 
and antibiotic pressure or other environmental factors that are known for transforming enterococcal 
normal flora to potential pathogens13.  
5. CONCLUSIONS 
It can be concluded from this study that irrational use of vancomycin and other antibiotics, and poor clinical 
practice might have contributed to increase prevalence of VRE. This study reports vanA gene cluster 
responsible for resistance in Pakistani population that warrants effective intervention strategies to inhibit 
VRE. 
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